4.3 Article

Reduction of sortilin-I in Alzheimer hippocampus and in cytokine-stressed human brain cells

期刊

NEUROREPORT
卷 18, 期 11, 页码 1187-1191

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0b013e32821c56c4

关键词

Alzheimer's disease; amyloid-beta 42 peptides; beta-amyloid precursor protein processing; brain gene expression; cholesterol; inflammatory signaling; lipoprotein receptors; SORLI/LRII; sortilin

资金

  1. NIA NIH HHS [NIA AG18031] Funding Source: Medline

向作者/读者索取更多资源

Sortilin I (SORLI) is a transmembrane sorting receptor that regulates the intracellular trafficking of beta-amyloid precursor protein (beta APP). Interactions between SORLI and PAPP result in the decreased processing of PAPP into toxic amyloid-beta 42 (A beta 42) peptides that accumulate in Alzheimer's disease brain. Here, we report selectively decreased levels of SORLI in limbic and occipital regions of Alzheimer brain that inversely correlate with amyloid plaque and neurofibrillary tangle density. Reduced SORLI, coupled to elevated beta-amyloid cleaving enzyme, presenilin-I and increased A beta 42 peptide secretion, was observed after incubation of cultured human neural cells with the proinflammatory cytokine interleukin-I beta The results suggest that SORLI deficits may not only promote the pathogenic processing of beta APP but may also contribute to A beta 42-mediated inflammatory signaling in stressed human brain cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据